Ralf Lutterbuese
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 14
- Radiopharmaceutical Chemistry and Applications 3
- Oncology 13
- CAR-T cell therapy research 10
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Peter Kufer (15 shared papers)Patrick A. Baeuerle (12 shared papers)Bernd Schlereth (7 shared papers)Tobias Raum (9 shared papers)Klaus Brischwein (5 shared papers)Roman Kischel (9 shared papers)Grit Lorenczewski (5 shared papers)Doris Rau (5 shared papers)
- Journals
- Cancer Research (7 papers)Molecular Cancer Therapeutics (2 papers)Journal of Immunotherapy (2 papers)Leukemia Research (1 paper)Molecular Immunology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Ralf Lutterbuese
15 papers receiving 807 citations
Peers
Comparison fields: 5 of 53
- Radiology, Nuclear Medicine and Imaging 523
- Oncology 615
- Immunology 393
- Biotechnology 42
- Molecular Biology 283
Countries citing papers authored by Ralf Lutterbuese
This map shows the geographic impact of Ralf Lutterbuese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Lutterbuese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Lutterbuese more than expected).
Fields of papers citing papers by Ralf Lutterbuese
This network shows the impact of papers produced by Ralf Lutterbuese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Lutterbuese. The network helps show where Ralf Lutterbuese may publish in the future.
Co-authors
The 25 scholars most cited alongside Ralf Lutterbuese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 212 | |
| 2 | 2010 | 123 | |
| 3 | 2012 | 109 | |
| 4 | 2005 | 101 | |
| 5 | 2008 | 68 | |
| 6 | 2007 | 66 | |
| 7 | 2009 | 64 | |
| 8 | 2008 | 58 | |
| 9 | 2009 | 43 | |
| 10 | 2017 | 23 | |
| 11 | Therapeutic window of MuS110, a single-chain antibody construct bispecific for EpCAM (CD326) and CD3 | 2007 | 3 |
| 12 | Conversion of Cetuximab and Trastuzumab into T cell-engaging BiTE antibodies creates novel drug candidates with superior anti-tumor activity | 2008 | 3 |
| 13 | 2017 | 1 | |
| 14 | 2016 | 1 | |
| 15 | 2011 | 1 |
About Ralf Lutterbuese
Ralf Lutterbuese is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Immunology, Molecular Biology and Surgery, having authored 15 papers that have together received 876 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Colorectal Cancer Treatments and Studies (1 paper), Cancer Genomics and Diagnostics (1 paper), Cancer Research and Treatments (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (523 citations), Oncology (615 citations), Immunology (393 citations), Biotechnology (42 citations) and Molecular Biology (283 citations). Ralf Lutterbuese has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Peter Kufer, Patrick A. Baeuerle, Bernd Schlereth, Tobias Raum, Klaus Brischwein, Roman Kischel, Grit Lorenczewski, Doris Rau, Andreas Wolf and Petra Kleindienst. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Immunotherapy, Leukemia Research and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.